{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T23:31:39Z","timestamp":1682638299571},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["VHRM"],"DOI":"10.2147\/vhrm.s5839","type":"journal-article","created":{"date-parts":[[2010,9,10]],"date-time":"2010-09-10T04:39:47Z","timestamp":1284093587000},"page":"457","source":"Crossref","is-referenced-by-count":2,"title":["Role of clevidipine butyrate in the treatment of acute hypertension in the critical care setting: a review"],"prefix":"10.2147","author":[{"given":"Michael","family":"Goldberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Awad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2010,6]]},"container-title":["Vascular Health and Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=6491","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:03:19Z","timestamp":1477864999000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/role-of-clevidipine-butyrate-in-the-treatment-of-acute-hypertension-in-peer-reviewed-article-VHRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/vhrm.s5839","relation":{},"ISSN":["1178-2048"],"issn-type":[{"value":"1178-2048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}